Comparison of Vocal Biomarkers for Depression and Anxiety to Formal Clinical Assessments
NCT ID: NCT06464575
Last Updated: 2024-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
540 participants
OBSERVATIONAL
2024-01-12
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vocal Acoustic Biomarkers in Depression
NCT00844948
Using Voice Biomarkers to Predict the Likelihood of Major Depressive Disorder
NCT04874077
Research on Voice Intelligent Monitoring Technology for Early Warning of Recurrence of Depression Disorder
NCT04685083
Sensor-based Characterization of Depression
NCT04370002
Use of Conversation and Acoustic Signals in Measuring Depression Severity
NCT00831935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Access to smartphone or computer with microphone
* Provision of esigned and dated informed consent form
* Willingness to adhere to the study protocol
Exclusion Criteria
* Under the influence of recreational drugs or alcohol
* Ill or experiencing heavy allergies or temporary conditions affecting respiration, voice, or speaking.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ellipsis Health
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ellipsis Health
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00070013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.